These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 11777274)
1. Utility of thyroid transcription factor-1 and cytokeratin 7 and 20 immunostaining in the identification of origin in malignant effusions. Jang KY; Kang MJ; Lee DG; Chung MJ Anal Quant Cytol Histol; 2001 Dec; 23(6):400-4. PubMed ID: 11777274 [TBL] [Abstract][Full Text] [Related]
2. [Use of thyroid transcription factor-1, surfacfant protein-B, cytokeratin 7 and cytokeratin 20 in discrimination between primary and metastatic adenocarcinoma of lung]. Zou SM; Lin DM; Lü N; Liu XY; Wen P; Liu FS Zhonghua Yi Xue Za Zhi; 2003 Aug; 83(15):1350-2. PubMed ID: 12930693 [TBL] [Abstract][Full Text] [Related]
3. Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens. Chhieng DC; Cangiarella JF; Zakowski MF; Goswami S; Cohen JM; Yee HT Cancer; 2001 Oct; 93(5):330-6. PubMed ID: 11668468 [TBL] [Abstract][Full Text] [Related]
4. Role of TTF-1, CK20, and CK7 immunohistochemistry for diagnosis of primary and secondary lung adenocarcinoma. Su YC; Hsu YC; Chai CY Kaohsiung J Med Sci; 2006 Jan; 22(1):14-9. PubMed ID: 16570563 [TBL] [Abstract][Full Text] [Related]
5. Utility of thyroid transcription factor-1 and CDX-2 in determining the primary site of metastatic adenocarcinomas in serous effusions. Kim JH; Choi YD; Lee JS; Lee JH; Nam JH; Choi C Acta Cytol; 2010; 54(3):277-82. PubMed ID: 20518411 [TBL] [Abstract][Full Text] [Related]
6. Use of caveolin-1, thyroid transcription factor-1, and cytokeratins 7 and 20 in discriminating between primary and secondary pulmonary adenocarcinoma from breast or colonic origin. Tsao SC; Su YC; Wang SL; Chai CY Kaohsiung J Med Sci; 2007 Jul; 23(7):325-31. PubMed ID: 17606426 [TBL] [Abstract][Full Text] [Related]
7. Cytokeratin 7 and 20 and thyroid transcription factor 1 can help distinguish pulmonary from gastrointestinal carcinoid and pancreatic endocrine tumors. Cai YC; Banner B; Glickman J; Odze RD Hum Pathol; 2001 Oct; 32(10):1087-93. PubMed ID: 11679943 [TBL] [Abstract][Full Text] [Related]
8. Tracing the origin of adenocarcinomas with unknown primary using immunohistochemistry: differential diagnosis between colonic and ovarian carcinomas as primary sites. Lagendijk JH; Mullink H; Van Diest PJ; Meijer GA; Meijer CJ Hum Pathol; 1998 May; 29(5):491-7. PubMed ID: 9596273 [TBL] [Abstract][Full Text] [Related]
9. Thyroid transcription factor-1 and cytokeratins 7 and 20 in pulmonary and breast carcinoma. Harlamert HA; Mira J; Bejarano PA; Baughman RP; Miller MA; Whitsett JA; Yassin R Acta Cytol; 1998; 42(6):1382-8. PubMed ID: 9850647 [TBL] [Abstract][Full Text] [Related]
10. Villin, cytokeratin 7, and cytokeratin 20 expression in pulmonary adenocarcinoma with ultrastructural evidence of microvilli with rootlets. Tan J; Sidhu G; Greco MA; Ballard H; Wieczorek R Hum Pathol; 1998 Apr; 29(4):390-6. PubMed ID: 9563790 [TBL] [Abstract][Full Text] [Related]
11. Expression of cytokeratin 20 in mucinous bronchioloalveolar carcinoma. Shah RN; Badve S; Papreddy K; Schindler S; Laskin WB; Yeldandi AV Hum Pathol; 2002 Sep; 33(9):915-20. PubMed ID: 12378517 [TBL] [Abstract][Full Text] [Related]
12. Cytokeratins 20 and 7 as biomarkers: usefulness in discriminating primary from metastatic adenocarcinoma. Tot T Eur J Cancer; 2002 Apr; 38(6):758-63. PubMed ID: 11937308 [TBL] [Abstract][Full Text] [Related]
13. Panels of immunohistochemical markers help determine primary sites of metastatic adenocarcinoma. Park SY; Kim BH; Kim JH; Lee S; Kang GH Arch Pathol Lab Med; 2007 Oct; 131(10):1561-7. PubMed ID: 17922593 [TBL] [Abstract][Full Text] [Related]
14. The value of cytokeratins 20 and 7 in discriminating metastatic adenocarcinomas from pleural mesotheliomas. Tot T Cancer; 2001 Nov; 92(10):2727-32. PubMed ID: 11745209 [TBL] [Abstract][Full Text] [Related]
15. Use of cytokeratins 7 and 20 in determining the origin of metastatic carcinoma of unknown primary, with special emphasis on lung cancer. Rubin BP; Skarin AT; Pisick E; Rizk M; Salgia R Eur J Cancer Prev; 2001 Feb; 10(1):77-82. PubMed ID: 11263595 [TBL] [Abstract][Full Text] [Related]
16. Expression of cytokeratins 7 and 20 in primary carcinomas of the stomach and colorectum and their value in the differential diagnosis of metastatic carcinomas to the ovary. Park SY; Kim HS; Hong EK; Kim WH Hum Pathol; 2002 Nov; 33(11):1078-85. PubMed ID: 12454811 [TBL] [Abstract][Full Text] [Related]
17. The clinical relevance of cytokeratin phenotyping in needle biopsy of liver metastasis. Tot T; Samii S APMIS; 2003 Dec; 111(12):1075-82. PubMed ID: 14678015 [TBL] [Abstract][Full Text] [Related]
18. Differential expression of cytokeratins 7 and 20 and thyroid transcription factor-1 in bronchioloalveolar carcinoma: an immunohistochemical study in fine-needle aspiration biopsy specimens. Simsir A; Wei XJ; Yee H; Moreira A; Cangiarella J Am J Clin Pathol; 2004 Mar; 121(3):350-7. PubMed ID: 15023039 [TBL] [Abstract][Full Text] [Related]
19. Primary signet-ring cell carcinoma of lung: immunohistochemical study and comparison with non-pulmonary signet-ring cell carcinomas. Merchant SH; Amin MB; Tamboli P; Ro J; Ordóñez NG; Ayala AG; Czerniak BA; Ro JY Am J Surg Pathol; 2001 Dec; 25(12):1515-9. PubMed ID: 11717541 [TBL] [Abstract][Full Text] [Related]
20. The value of immunohistochemical expression of TTF-1, CK7 and CK20 in the diagnosis of primary and secondary lung carcinomas. Al-Zahrani IH Saudi Med J; 2008 Jul; 29(7):957-61. PubMed ID: 18626520 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]